Decoy Therapeutics Inc
NASDAQ:DCOY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Decoy Therapeutics Inc
NASDAQ:DCOY
|
US |
|
C
|
China Construction Bank Corp
DUS:C6T
|
CN |
|
S
|
Sparebank 1 Ostfold Akershus
OSE:SOAG
|
NO |
|
Kitron ASA
F:KP5
|
NO |
|
CleanBnB SpA
MIL:CBB
|
IT |
|
A
|
Air Products and Chemicals Inc
BMV:APD
|
US |
|
Toray Industries Inc
TSE:3402
|
JP |
|
Fomento de Construcciones y Contratas SA
OTC:FMOCF
|
ES |
|
Wolters Kluwer NV
AEX:WKL
|
NL |
|
I
|
Intuit Inc
SWB:ITU
|
US |
|
Ardelyx Inc
NASDAQ:ARDX
|
US |
|
Isracard Ltd
OTC:ISCDF
|
IL |
|
Schindler Holding AG
F:SHR
|
CH |
|
K
|
Kawasaki Heavy Industries Ltd
XMUN:KHE
|
JP |
|
T
|
Teva Pharmaceutical Industries Ltd
SWB:TEV
|
IL |
|
Y
|
Yangzijiang Shipbuilding (Holdings) Ltd
SWB:B8O
|
CN |
Bankruptcy Probability
Decoy Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Decoy Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Decoy Therapeutics Inc
NASDAQ:DCOY
|
1.5m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
450.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
206.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
179.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
80B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
54.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
46.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
43.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Decoy Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Decoy Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
